---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-279428"
form_type: "8-K"
ticker: "JANX"
cik: "0001817713"
company_name: "Janux Therapeutics, Inc."
filed_at: "2026-06-23T20:05:31+00:00"
generated_at: "2026-06-23T20:07:40.515298+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Janux Therapeutics CMO Dr. William Go departs; no impact on clinical timelines

## Summary
- CMO William Go, M.D., Ph.D. departed June 23, 2026; company determined termination without Cause under severance plan.
- Company initiated search for successor; existing clinical leadership team assumes interim responsibilities.
- Departure not due to disagreement with company on operations, policies, or practices.
- Transition does not affect development strategy, regulatory plans, or previously disclosed clinical timelines.

## SEC filing metadata
- accession: 0001193125-26-279428
- form_type: 8-K
- ticker: JANX
- cik: 0001817713
- company_name: Janux Therapeutics, Inc.
- filed_at: 2026-06-23T20:05:31+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1817713/000119312526279428/0001193125-26-279428-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1817713/000119312526279428/janx-20260623.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-279428
- JSON: https://secwatch.observer/filing/0001193125-26-279428.json
- Plain text: https://secwatch.observer/filing/0001193125-26-279428.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.